Created in 2009, the health industry alliance for research and innovation (ARIIS) is made up of worldwide pharmaceutical and diagnostic companies. Reactive and agile , it’s a "start-up on the shoulders of giants". The Alliance organises preclinical research events and implements national industrial projects, in particular on health data. ARIIS is also in charge of national plans and roadmaps on various innovative subjects, with its historic partner, the public alliance Aviesan. For more information, visit our website

Bpifrance is the French national investment bank: it supports businesses – at every stage of their development – mainly micro-businesses, SMEs and mid-caps but we also accompany large caps that are considered important to the interests of France in terms of national economy, the territories or employment. We offer a continuum of solutions adapted to every key step in a business’ growth such as: business creation, financing, loans, guarantees, export insurance or equity investment. We are also the French agency for innovation, delivering massive programs to innovative entrepreneurs. Bpifrance also provides extrafinancial services (training, consultancy) to help entrepreneurs meet their challenges.

For more information, visit our website

Founded in 1997, France Biotech is an independent association that brings together HealthTech entrepreneurs and their expert partners. It actively contributes to meet the many challenges of the HealthTech industry (i.e. companies’ financing, innovation-related taxes, regulatory and market access related issues) and offers concrete competition and solutions through its commissions and working groups. The goal is to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients.

For more information, visit our websit

Founded in 1964, Inserm is a public scientific and technological institute which operates under the joint authority of the French Ministries of Health and Research.

The institute is dedicated to biomedical research and human health, and is involved in the entire range of activities from the laboratory to the patient’s bedside.

It also partners with the most prestigious research institutions in the world that are committed to scientific challenges and progress in these fields.

For more information, visit our website

Leem is the French industry association which represents drug companies operating in France. On a national level, Leem acts as a champion and advocate for the pharmaceutical industry. In this capacity, it participates in numerous official, ministerial and inter-ministerial committees, is engaged in agreement-based policy with the State, negotiates with social partners and promotes ethical standards.
Leem is a member of the French Federation of Healthcare Industries (FEFIS) and of the French Enterprise Movement (MEDEF). At international level, Leem is a member of the European Federation of Pharmaceutical Associations and Industries (EFPIA) and of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA).

For more information, visit our website